Literature DB >> 8387930

Valproate and sodium currents in cultured hippocampal neurons.

R J Van den Berg1, P Kok, R A Voskuyl.   

Abstract

Cultured rat hippocampal neurons with short processes were investigated using the whole cell voltage clamp under conditions appropriate for isolating Na+ currents. After incubation of the neuron culture for a period of 15-30 min in 1 mM sodium valproate, several parameters of the Na+ current were changed. The peak Na+ conductance gp, measured using hyperpolarizing prepulses, was reduced by valproate in a voltage-dependent manner. In the membrane voltage range from -30 to +20 mV, this reduction showed a linear dependence on voltage, increasing from about zero to approximately 30% of gp, the maximum peak Na+ conductance of the neuron. At the holding voltage of -70 mV, the inactivation parameter h infinity decreased from 0.88 in the control to 0.64 in the valproate solution. This reduction originated mainly from a 10 mV shift in the sigmoid relation between h infinity and membrane voltage along the voltage axis to hyperpolarizing potentials. The decay of the maximum peak Na+ current (inactivation) could be fitted by a biexponential function. Time constants of the fast and slow component at -20 mV decreased in valproate by about 50%. Valproate also retarded the recovery from inactivation, as determined at the holding voltage. The sigmoid recovery from inactivation could reasonably be described by an exponential function with time constant tau r and delay time delta t. Both tau r and delta t increased more than 200% in valproate. Our results indicate that valproate affected the Na+ current in hippocampal neurons in a way that contributed to a considerable depression of Na+ reactivation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387930     DOI: 10.1007/bf00228395

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  29 in total

Review 1.  Neurophysiological and biochemical changes evoked by valproic acid in the central nervous system.

Authors:  D Cotariu; J L Zaidman; S Evans
Journal:  Prog Neurobiol       Date:  1990       Impact factor: 11.685

2.  Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture.

Authors:  M J McLean; R L Macdonald
Journal:  J Pharmacol Exp Ther       Date:  1986-06       Impact factor: 4.030

3.  Time constants and electrotonic length of membrane cylinders and neurons.

Authors:  W Rall
Journal:  Biophys J       Date:  1969-12       Impact factor: 4.033

4.  Micro-CO2-incubator for use on a microscope.

Authors:  C Ince; D L Ypey; M M Diesselhoff-Den Dulk; J A Visser; A De Vos; R Van Furth
Journal:  J Immunol Methods       Date:  1983-05-27       Impact factor: 2.303

5.  A reinterpretation of mammalian sodium channel gating based on single channel recording.

Authors:  R W Aldrich; D P Corey; C F Stevens
Journal:  Nature       Date:  1983 Dec 1-7       Impact factor: 49.962

6.  Passive cable properties of hippocampal CA3 pyramidal neurons.

Authors:  D Johnston
Journal:  Cell Mol Neurobiol       Date:  1981-03       Impact factor: 5.046

7.  Bepridil and valproate retard Na+ reactivation in Myxicola.

Authors:  C L Schauf
Journal:  Eur J Pharmacol       Date:  1987-06-12       Impact factor: 4.432

8.  Comparative pharmacodynamics and brain distribution of E-delta 2-valproate and valproate in rats.

Authors:  R L Semmes; D D Shen
Journal:  Epilepsia       Date:  1991 Mar-Apr       Impact factor: 5.864

9.  Evidence for two transient sodium currents in the frog node of Ranvier.

Authors:  E Benoit; A Corbier; J M Dubois
Journal:  J Physiol       Date:  1985-04       Impact factor: 5.182

10.  Effects induced by the antiepileptic drug valproic acid upon the ionic currents recorded in rat neocortical neurons in cell culture.

Authors:  C Zona; M Avoli
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

View more
  10 in total

Review 1.  Modulation and pharmacology of low voltage-activated ("T-Type") calcium channels.

Authors:  Anne Marie R Yunker
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

2.  Reduction of spike generation frequency by cooling in brain slices from rats and from patients with epilepsy.

Authors:  Sadahiro Nomura; Hiroyuki Kida; Yuya Hirayama; Hirochika Imoto; Takao Inoue; Hiroshi Moriyama; Dai Mitsushima; Michiyasu Suzuki
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-17       Impact factor: 6.200

3.  Effect of valproate, lamotrigine and levetiracetam on excitability and firing properties of CA1 neurons in rat brain slices.

Authors:  Marita Englund; Lars Hyllienmark; Tom Brismar
Journal:  Cell Mol Neurobiol       Date:  2011-02-19       Impact factor: 5.046

Review 4.  Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.

Authors:  Wolfgang Löscher
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

5.  Valproic acid pathway: pharmacokinetics and pharmacodynamics.

Authors:  Yogita Ghodke-Puranik; Caroline F Thorn; Jatinder K Lamba; J Steven Leeder; Wen Song; Angela K Birnbaum; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2013-04       Impact factor: 2.089

Review 6.  Complex Combination Pharmacotherapy for Bipolar Disorder: Knowing When Less Is More or More Is Better.

Authors:  Joseph F Goldberg
Journal:  Focus (Am Psychiatr Publ)       Date:  2019-07-16

7.  Effects of anti-epileptic drugs on spreading depolarization-induced epileptiform activity in mouse hippocampal slices.

Authors:  Ching-Huei Lin; Shih-Pin Hsu; Ting-Chun Cheng; Chin-Wei Huang; Yao-Chang Chiang; I-Han Hsiao; Ming-Hsueh Lee; Mei-Lin Shen; Dong Chuan Wu; Ning Zhou
Journal:  Sci Rep       Date:  2017-09-19       Impact factor: 4.379

Review 8.  Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile.

Authors:  Manish Kumar Mishra; Samiksha Kukal; Priyanka Rani Paul; Shivangi Bora; Anju Singh; Shrikant Kukreti; Luciano Saso; Karthikeyan Muthusamy; Yasha Hasija; Ritushree Kukreti
Journal:  Molecules       Date:  2021-12-24       Impact factor: 4.411

Review 9.  Pharmacogenetics in Primary Headache Disorders.

Authors:  Irina I Belyaeva; Anna G Subbotina; Ivan I Eremenko; Vadim V Tarasov; Vladimir N Chubarev; Helgi B Schiöth; Jessica Mwinyi
Journal:  Front Pharmacol       Date:  2022-02-10       Impact factor: 5.810

10.  Association of SCN1A, SCN2A, and UGT2B7 Polymorphisms with Responsiveness to Valproic Acid in the Treatment of Epilepsy.

Authors:  Yuan Lu; Quanping Su; Ming Li; Alimu Dayimu; Xiaoyu Dai; Zhiheng Wang; Fengyuan Che; Fuzhong Xue
Journal:  Biomed Res Int       Date:  2020-02-25       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.